Cyrla Zaltman
Instituição:
Universidade Federal do Rio de Janeiro
Centro:
Centro de Ciências da Saúde
Unidade:
Faculdade de Medicina
Departamento:
Departamento de Clínica Médica/FM
Formação:
-
Hospital Clinic Barcelona
| Pós-Doutorado | 2011 - 2011
-
Universidade Federal de São Paulo
Gastroenterologia | Doutorado | 1994 - 1997
-
Universidade Federal do Rio de Janeiro
Clínica Médica | Mestrado | 1984 - 1987
-
Instituto Nacional de Assistencia Medica da Previdencia Social
| Especialização - Residência medica | 1982 - 1984
-
Instituto Nacional de Assistencia Medica da Previdencia Social
| Especialização - Residência medica | 1980 - 1982
-
Universidade Federal do Rio de Janeiro
Medicina | Graduação | 1973 - 1979
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:
(48.51% artigos com DOI)
Titulo | DOI | Ano |
---|---|---|
Ambient air pollution and inflammatory bowel disease?a narrative review | 10.21037/dmr-23-12 | 2024 |
Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIB | 10.1038/s41598-024-54332-1 | 2024 |
Consenso de endoscopia en enfermedad inflamatoria intestinal de la Organización Panamericana de Crohn y Colitis (PANCCO) y la Sociedad Interamericana de endoscopia (SIED) | 10.47892/rgp.2024.442.1713 | 2024 |
Second Brazilian Consensus on the Management of Crohn?s disease in adults: a consensus of the Brazilian Organization for Crohn?s Disease and Colitis (GEDIIB) | 10.1590/S0004-2803.2022005S1-02 | 2023 |
Second Brazilian consensus on the management of ulcerative colitis in adults: a consensus of the Brazilian Organization for Crohn?s Disease and Colitis (GEDIIB) | 10.1590/S0004-2803.2022005S1-03 | 2023 |
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial | 10.1016/s2468-1253(22)00427-7 | 2023 |
S71-Evaluation of the Quality-of-Care Parameters in Patients With Inflammatory Bowel Disease in Brazilian Hospitals | 10.14309/01.ajg.0000996028.23348.9c | 2023 |
Actualización de la guía de práctica clínica PANCCO para el tratamiento de la colitis ulcerativa en población adulta | 10.1016/j.rgmx.2022.04.007 | 2022 |
COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN BRAZILIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE | 10.1590/s0004-2803.202203000-68 | 2022 |
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials | 10.1016/s2468-1253(21)00338-1 | 2022 |
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial | 10.1016/s2468-1253(21)00298-3 | 2022 |
Tu1545: TRANS-CONTINENTAL ANALYSIS OF OVER 2,000 INFLAMMATORY BOWEL DISEASE PATIENTS IMPLICATES GEOGRAPHY, DISEASE TYPE, AND EXPOSURE TO IMMUNOSUPPRESSION AS DRIVERS OF SARS-COV-2 SEROPREVALENCE | 10.1016/S0016-5085(22)62383-7 | 2022 |
Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil | 10.3748/wjg.v27.i2.208 | 2021 |
Hospitalization and surgery rates in patients with inflammatory bowel disease in Brazil: a time-trend analysis | 10.1186/s12876-021-01781-x | 2021 |
Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil. | 10.3748/wjg.v27.i23.3396. | 2021 |
Severe Necrotising Toxoplasmic Retinochoroiditis in a Patient With Crohn?s Disease in Use of Adalimumab and Azathioprine | 10.1093/ibd/izaa105 | 2020 |
RISK FACTORS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE: A MULTICENTER CASE-CONTROL STUDY IN BRAZIL | 10.3748/wjg.v26.i25.3611 | 2020 |
Review of the epidemiology and burden of ulcerative colitis in Latin America | 10.1177/ 1756284820931739 | 2020 |
THE USE OF CURCUMIN AS A COMPLEMENTARY THERAPY IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED CLINICAL TRIALS | 10.3390/nu12082296 | 2020 |
P072-The Pathway IBD Care in Rio de Janeiro From a Tertiary Referral Center Point of View | 10.14309/01.ajg.0000723084.20473.b7 | 2020 |
P061 Prophylaxis of Hepatitis B Reactivation and Inflammatory Bowel Disease: A case report | 10.14309/01.ajg.0000723040.923.. | 2020 |
Current overview on hospitalization and surgery in inflammatory bowel disease | 2020 | |
Enviromental factors ( exposome) associated to inflammatory bowel disease | 2020 | |
The optimal time to perform an ophthalmic examination of patients with inflammatory bowel disease | 10.5217/ir.2018.00147 | 2019 |
The Role of Clinical-Demographic Characteristics in Ophthalmic Manifestations of Inflammatory Bowel Disease | 10.1093/ibd/izy159 | 2019 |
Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases | 10.1186/s42358-019-0056-x | 2019 |
Crohns disease - treatment with biological medication | 10.1590/1806-9282.65.4.554 | 2019 |
Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil | 10.3748/wjg.v25.i38.5862 | 2019 |
Situaciones especiales en la enfermedad inflamatoria intestinal: primer consenso latinoamericano de la Pan American Crohn's and Colitis Organisation (PANCCO) (Segunda parte) | 10.1016/j.rgmx.2016.07.005 | 2017 |
Ophthalmic manifestations in patients with inflammatory bowel disease: A review | 10.3748/wjg.v23.i32.5836 | 2017 |
INTERAÇÕES MEDICAMENTOSAS NO TRATAMENTO DE DOENÇAS INFLMATÓRIAS INTESTINAIS | 10.5216/ref.v14i2.46022 | 2017 |
Extraintestinal neoplasia and inflammatory bowel disease | 2017 | |
Diagnóstico y tratamiento de la enfermedad inflamatoria intestinal: Primer Consenso Latinoamericano de la Pan American Crohn's and Colitis Organisation | 10.1016/j.rgmx.2016.07.003 | 2016 |
Common NOD2/CARD15 and TLR4 Polymorphisms Are Associated with Crohn?s Disease Phenotypes in Southeastern Brazilians | 10.1007/s10620-016-4172-8 | 2016 |
Differential Diagnosis between Crohn's disease and Intestinal tuberculosis in Brazil and other regions with high incidence of tuberculosis: A chronic and current dilemma | 2015 | |
Practical approach to anemia in inflammatory bowel disease | 2015 | |
High prevalence of vitamin A deficiency in Crohn's disease patients according to serum retinol levels and the relative dose-response test | 2015 | |
Lower extremity mobility limitation and impaired muscle function in women with ulcerative colitis | 10.1016/j.crohns.2013.11.006 | 2014 |
Progressive resistance training improves muscle strength in women with inflammatory bowel disease and quadriceps weakness | 10.1016/j.crohns.2014.09.001 | 2014 |
FOCAL ENHANCED GASTRITIS AND MACROPHAGE MICROAGGREGATES IN THE GASTRIC MUCOSA: potential role in the differential diagnosis between Crohn’s disease and ulcerative colitis | 10.1590/S0004-28032014000400003 | 2014 |
Does active Crohn's disease have decreased intestinal antioxidant capacity? | 10.1016/j.crohns.2013.02.010 | 2013 |
Subgingival microflora in inflammatory bowel disease patients with untreated periodontitis | 10.1097/meg.0b013e32835a2b70 | 2013 |
A Randomized Controlled Trial Of the Efficacy and Safety of CCX282-B, an orrally -adminstered blocker of chemokine receptor CCR9, for patients with Crohn´s disease | 2013 | |
Pseudomelanosis duodeni associated with chronic renal failure | 10.3748/wjg.v18.i12.1414 | 2012 |
Wireless Capsule Endoscopy Fragmentation in a Patient with Crohn's Disease | 10.1016/j.cgh.2011.04.018 | 2011 |
Deficiência de ferro nas afecções gastrointestinais do adulto | 10.1590/S1516-84842010005000063 | 2010 |
Consensus guidelines for the management of inflammatory bowel disease | 10.1590/S0004-28032010000300019 | 2010 |
Eficacia dos antagonistas do TNF alem de um ano nas doenças inflamatorias intestinais em adultos e crianças- revisao sistematica | 2010 | |
In Vitro Ultrasound biomicroscopy imaging of colitis on rats | 2009 | |
Intramural esophageal hematoma after elective injection sclerotherapy | 10.1590/S0004-28032009000400006 | 2009 |
Hepatitis B virus prevalence and transmission risk factors in inflammatory bowel disease patients at Clementino Fraga Filho university hospital | 10.3748/wjg.14.3201 | 2008 |
Prevalence of periodontitis and DMFT index in patients with Crohn's disease and ulcerative colitis | 10.1111/j.1600-051X.2008.01231.x | 2008 |
Doença de Crohn | 2008 | |
Prevalência de Periodontite em Pacientes com Doença Inflamatória Intestinal | 2008 | |
Quality-of-life measurement in patients with inflammatory bowel disease receiving social support | 10.1002/ibd.20071 | 2007 |
Doença inflamatória intestinal: qual a relevância da doença no Brasil? | 10.1590/S0102-311X2007000500001 | 2007 |
Analise descritiva dos perfis social, clinico, laboratorial e antropométrico de pacientes com doenças inflamatórias intestinais, internados no hospital UNiversitario Clementino Fraga Filho, Rio de Janeiro | 10.1590/S0004-28032007000400010. | 2007 |
Bronchial hyperresponsiveness and analysis of induced sputum cells in Crohn's disease | 10.1590/S0100-879X2005000200007 | 2005 |
The influence of aminosalicilates in the prevalence of H pylori infection in patients with inflammatory bowel disease | 2005 | |
Use of 99mTC mononuclear lekocyte scintigraphy in patients with Crohn's disease and irritable intestinal syndrome: Is differential diagnosis possible? | 2005 | |
Gene expression profiles in the intestinal mucosa of ulcerative colitis | 2005 | |
Muscle performance and BMI in patients with inflammatory bowel disease | 2005 | |
Quality of life measurement in patients with inflammatory bowel disease having social support | 2005 | |
Colordopplerfluxometry study of the abdominal vessels in patients with Crohn's disease | 2005 | |
Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence for altered expression of FasL and perforin cytotoxic pathways | 2005 | |
Prevalence of hepatitis C virus and evaluation of associated risk factors in a group of Brazilian patients with inflammatory bowel disease | 2005 | |
Small bowel of patients with asthma and allergic rhinites:no inflammation despite the presence of major cellular components of allergic inflammation | 2004 | |
Estudo por Dopplerfluxometria colorida das artérias aorta e mesentárica superior em pacientes com D Crohn. resultados preliminares | 2004 | |
Long Chain Fatty Acid Uptake by Human Intestinal Mucosa in vitro: Mechanisms of Transport | 10.1159/000069700 | 2003 |
Intestinal T cell lymphoma with and without celiac disease: report of two cases | 2003 | |
Intestinal T-cell lymphoma with and without celiac disease: a report of two cases. | 2003 | |
Upper gastrointestinal bleeding in a Brazilian hospital: a retrospective study of endoscopic records | 10.1590/S0004-28032002000200002 | 2002 |
Quantitative assessment of intestinal eosinophil in chronic inflammatory diseases of the gut and respiratory tract | 2001 | |
Patient's diets in a brazilian adult population with inflammatory bowel dises | 2001 | |
Enteropathy- associated intestinal T Cell lymphoma with and without celiac disease | 2001 | |
Avaliação Nutricional inicial na Doença Inflamatória Intestinal (DII) em ambulatório especializado no HUCFF-UFRJ | 2001 | |
Tumores Carcinóides do Trato Digestivo alto no HUCFF-UFRJ | 2000 | |
Prevalence p-ANCA in a Brazilian Population with inflammatory bowel disease and its correlation with disease activity | 2000 | |
Perfil dietético de pacientes com doença inflamatória intestinal no HUCFF-UFRJ | 2000 | |
Frequencia de P-ANCA em pacientes com retocolite ulcerativa e D. de Crohn no ambultório de doença inflamatória intestinal do Hospital Universitário Clementino Fraga Filho | 2000 | |
Prospective Evaluation of Upper gastrointestinal tract in patients with Crohn's disesase | 1999 | |
Small intestinal morphology in dermatitis herpertiformis: experience of the Federal University of Rio de Janeiro | 1998 | |
Upper GI bleeding: a study of emergency in an academic medical center (HUCFF-UFRJ) | 1998 | |
Detection of HCV RNA in liver biopsies using digoxigenin labelled PCR product as a probe: preliminary result | 1998 | |
Impacto da endoscopia digestiva no diagnóstico de afecções do trato digestivo alto em pacientes HIV- positivos | 1998 | |
Systemic Lupus Erytematous: Evidence of mononuclear cell depletion in the intestinal lamina propria | 1998 | |
Oral Nutritional Supplementation on the clinical and immunological status of AIDS 'patients | 1998 | |
Hemorragia digestiva alta: Estudo retrospectivo das urgências endoscópicas no HUCFF-UFRJ | 1997 | |
Role of different methods for detection of diarrhoeal pathogens in HIV- infected patients in Brazil | 1994 | |
Role of Different Methods for the Detection of Diarrhoeal Pathogens in HIV Patients in Brazil. | 1994 | |
Enemas de 5-Asa No Tratamento de Retocolite Ulcerativa Aguda: Ensaio Clinico Controlado. | 1988 | |
Giardiase: Aspectos Funcionais, Morfologicos e Imunologicos. | 1988 | |
Doenca Celiaca do Adulto: Aspectos Imunologicos. | 1987 | |
Degeneracao Hepato Lenticular. (Doenca de Wilson) - 4 Casos Entre Irmaos. | 1987 | |
Doenca de Crohn e O Sistema Imunologico Apenas Uma Teoria? | 1987 | |
Aspectos Imunológicos da Doença Celíaca do Adulto | 1987 | |
Hepatite Aguda Grave | 1986 | |
Experiencia Com Biopsia Per Oral do Intestino Delgado do Hospital Universitario da Ufrj. | 1986 | |
Doença de Crohn e Gravidez | 1986 | |
Anastomose Esplenorenal Seletiva e Hepatite Pos-Transfusional: Fllow-Up A Curto e Medio Prazos. | 1985 | |
Sub-oclusão Intestinal Crônica. Relato de Um Caso | 1984 |
Eventos:
(0.00% eventos com DOI)